| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 10 869-875, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
TL Brown, S Patil, RK Basnett and PH Howe
Department of Cell Biology (NC-1), The Lerner Research Insitute, Cleveland Clinic Foundation, Ohio 44195, USA.
Transforming growth factor beta (TGFbeta) is essential for immune regulation and growth control. TGFbeta has previously been shown to inhibit cell growth as well as induce cell death in lymphocytes, although the mechanisms controlling these processes are not well understood. The mouse pre-B lymphoma cell line WEHI 231 was used to examine the mechanisms of TGFbeta-mediated growth inhibition and apoptosis. TGFbeta inhibits the growth of WEHI 231 cells in a dose-dependent manner; however, a decrease in viability is also observed, which is indicative of increased cell death. TGFbeta induces oligonucleosomal DNA ladder formation in a dose-dependent manner, indicating the mechanism of cell death is via apoptosis. The broad spectrum caspase inhibitor BD-fmk, but not tetrapeptide inhibitors of specific caspases, completely blocks TGFbeta-induced apoptosis while maintaining cellular viability. BD-fmk, however, has no effect on TGFbeta-induced growth inhibition. The ability of TGFbeta to down-regulate cyclin A-associated kinase activity, postulated to mediate TGFbeta growth inhibition, is not affected by the caspase inhibitor BD-fmk. These results suggest that caspases do not regulate cell cycle mediators of growth and provide the first demonstration that a pharmacological inhibitor of TGFbeta-induced apoptosis is capable of distinguishing growth inhibitory from apoptotic pathways.
This article has been cited by other articles:
![]() |
J. Chen, M. Delannoy, S. Odwin, P. He, M. A. Trush, and J. D. Yager Enhanced Mitochondrial Gene Transcript, ATP, Bcl-2 Protein Levels, and Altered Glutathione Distribution in Ethinyl Estradiol-Treated Cultured Female Rat Hepatocytes Toxicol. Sci., October 1, 2003; 75(2): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Kim, M. Mamura, K. S. Choi, B. Calabretta, and S.-J. Kim Transforming Growth Factor {beta}1 Induces Apoptosis through Cleavage of BAD in a Smad3-Dependent Mechanism in FaO Hepatoma Cells Mol. Cell. Biol., March 1, 2002; 22(5): 1369 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Inman and M. J. Allday Apoptosis Induced by TGF-{beta}1 in Burkitt's Lymphoma Cells Is Caspase 8 Dependent But Is Death Receptor Independent J. Immunol., September 1, 2000; 165(5): 2500 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, M. Gokhale, B. Schofield, S. Odwin, and J. D. Yager Inhibition of TGF-{beta}-induced apoptosis by ethinyl estradiol in cultured, precision cut rat liver slices and hepatocytes Carcinogenesis, June 1, 2000; 21(6): 1205 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Brown, S. Patil, C. D. Cianci, J. S. Morrow, and P. H. Howe Transforming Growth Factor beta Induces Caspase 3-independent Cleavage of alpha II-Spectrin (alpha -Fodrin) Coincident with Apoptosis J. Biol. Chem., August 13, 1999; 274(33): 23256 - 23262. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Patil, G. M. Wildey, T. L. Brown, L. Choy, R. Derynck, and P. H. Howe Smad7 Is Induced by CD40 and Protects WEHI 231 B-lymphocytes from Transforming Growth Factor-beta -induced Growth Inhibition and Apoptosis J. Biol. Chem., December 1, 2000; 275(49): 38363 - 38370. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |